Shutdown bars FDA officials from attending conferences

10/4/2013 | PharmExec.com

The U.S. government shutdown prevented FDA and NIH officials from attending the Drug Information Association's Clinical Trial Disclosure conference in Maryland, and FDA participants had to leave the Regulatory Affairs Professionals Society meeting in Boston, Jill Wechsler writes. The FDA stopped routine drug manufacturing facility inspections and clinical research locations, as well as accepting new regulatory filings that carry fees, she writes. Possible consequences include delays in carrying out programs and issuing documents, as well as missed review deadlines. Many FDA employees may have to be removed from the agendas of upcoming conferences.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA